Innovation Biologicals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 17-11-2024
- Paid Up Capital ₹ 0.10 M
as on 17-11-2024
- Company Age 9 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 2.56 M
as on 17-11-2024
- Revenue -10.20%
(FY 2023)
- Profit 67.53%
(FY 2023)
- Ebitda 10.00%
(FY 2023)
- Net Worth 10.55%
(FY 2023)
- Total Assets 16.04%
(FY 2023)
About Innovation Biologicals
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹2.56 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Sanjay Nene, Subhash Kapre, Rajesh Shiralkar, and Two other members serve as directors at the Company.
- CIN/LLPIN
U74999PN2015PTC156830
- Company No.
156830
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Oct 2015
- Date of AGM
19 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Innovation Biologicals?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Nene  | Director | 13-Oct-2015 | Current |
Pradip Ghate  | Director | 11-Feb-2017 | Current |
Subhash Kapre  | Director | 01-Dec-2015 | Current |
| Rajesh Shiralkar | Director | 13-Oct-2015 | Current |
| Prabhakar Ranjekar | Director | 02-Nov-2015 | Current |
Financial Performance of Innovation Biologicals.
Innovation Biologicals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 10.2% decrease. The company also saw a substantial improvement in profitability, with a 67.53% increase in profit. The company's net worth Soared by an impressive increase of 10.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Innovation Biologicals?
In 2023, Innovation Biologicals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 31 Jul 2017 | ₹2.56 M | Satisfied |
How Many Employees Work at Innovation Biologicals?
Unlock and access historical data on people associated with Innovation Biologicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Innovation Biologicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Innovation Biologicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
